Target Name: SLC39A10
NCBI ID: G57181
Review Report on SLC39A10 Target / Biomarker Content of Review Report on SLC39A10 Target / Biomarker
SLC39A10
Other Name(s): Solute carrier family 39 member 10 | LZT-Hs2 | Zinc transporter ZIP10 | solute carrier family 39 (zinc transporter), member 10 | solute carrier family 39 (metal ion transporter), member 10 | Solute carrier family 39 (metal ion transporter), member 10 | Solute Carrier Family 39 (Zinc Transporter) Member 10 | ZRT/IRT-like protein 10 | Solute carrier family 39 member 10, transcript variant X4 | Solute carrier family 39 (zinc transporter), member 10 | ZIP-10 | solute carrier family 39 member 10 | SLC39A10 variant 1 | uncharacterized LOC107985971 | Zinc transporter ZIP10 (isoform X1) | ZIP10 | zrt- and Irt-like protein 10 | Solute carrier family 39 member 10, transcript variant 1 | DKFZp781L10106 | zinc transporter 10 | SLC39A10 variant X2 | Zrt- and Irt-like protein 10 | S39AA_HUMAN | MGC138428 | KIAA1265 | Solute carrier family 39 member 10,, transcript variant X2 | MGC126565 | SLC39A10 variant X4

SLC39A10: A Potential Drug Target for Cellular Signaling and Disease

SLC39A10, also known as SLC39A10, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It belongs to the Solute carrier family 39, which is a well-established family of proteins that play a critical role in the transport of various molecules across cell membranes. SLC39A10 is a member of this family and is involved in the transport of several different molecules, including nucleotides, amino acids, and ions.

One of the key functions of SLC39A10 is its role in the transport of nucleotides across cell membranes. Nucleotides are the building blocks of DNA and RNA, and they are essential for the proper functioning of many cellular processes. SLC39A10 is involved in the transport of nucleotides across the membrane of the cell, allowing them to be used by the cell for various functions, including DNA replication, RNA transcription, and cellular signaling.

In addition to its role in nucleotide transport, SLC39A10 is also involved in the transport of other molecules across cell membranes. For example, it is involved in the transport of amino acids across the membrane of the cell, which is essential for the synthesis of new proteins and the maintenance of cellular homeostasis. Additionally, SLC39A10 is also involved in the transport of ions across the membrane of the cell, which is essential for maintaining the proper levels of electrical charge in the cell.

SLC39A10 is also of interest as a potential drug target. The SLC39A10 protein has been shown to play a critical role in the development and progression of certain diseases, including cancer. For example, studies have shown that high levels of SLC39A10 are associated with poor prognosis in patients with pancreatic cancer, and that inhibiting the activity of SLC39A10 may be an effective way to treat this disease.

Another potential use of SLC39A10 as a drug target is its role in the regulation of cellular signaling. SLC39A10 is involved in the transport of several different signaling molecules across the membrane of the cell, including neurotransmitters and hormones. This suggests that SLC39A10 may play a critical role in the regulation of cellular signaling, and that targeting its activity may be an effective way to treat a variety of diseases.

In conclusion, SLC39A10 is a protein that is involved in the transport of various molecules across cell membranes, including nucleotides, amino acids, and ions. Its role in nucleotide and signaling molecule transport makes it an attractive target for drug development, particularly for the treatment of diseases where the regulation of cellular signaling is disrupted. Further research is needed to fully understand the role of SLC39A10 in cellular signaling and its potential as a drug target.

Protein Name: Solute Carrier Family 39 Member 10

Functions: May act as a zinc-influx transporter

The "SLC39A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC39A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SLC39A11 | SLC39A12 | SLC39A13 | SLC39A14 | SLC39A2 | SLC39A3 | SLC39A4 | SLC39A5 | SLC39A6 | SLC39A7 | SLC39A8 | SLC39A9 | SLC3A1 | SLC3A2 | SLC40A1 | SLC41A1 | SLC41A2 | SLC41A3 | SLC43A1 | SLC43A2 | SLC43A3 | SLC44A1 | SLC44A2 | SLC44A3 | SLC44A3-AS1 | SLC44A4 | SLC44A5 | SLC45A1 | SLC45A2 | SLC45A3 | SLC45A4 | SLC46A1 | SLC46A2 | SLC46A3 | SLC47A1 | SLC47A1P2 | SLC47A2 | SLC48A1 | SLC49A3 | SLC49A4 | SLC4A1 | SLC4A10 | SLC4A11 | SLC4A1AP | SLC4A2 | SLC4A3 | SLC4A4 | SLC4A5 | SLC4A7 | SLC4A8 | SLC4A9 | SLC50A1 | SLC51A | SLC51B | SLC52A1 | SLC52A2 | SLC52A3 | SLC5A1 | SLC5A10 | SLC5A11 | SLC5A12 | SLC5A2 | SLC5A3 | SLC5A4 | SLC5A4-AS1 | SLC5A5 | SLC5A6 | SLC5A7 | SLC5A8 | SLC5A9 | SLC66A1 | SLC66A1L | SLC66A2 | SLC66A3 | SLC6A1 | SLC6A1-AS1 | SLC6A10P | SLC6A10PB | SLC6A11 | SLC6A12 | SLC6A13 | SLC6A14 | SLC6A15 | SLC6A16 | SLC6A17 | SLC6A18 | SLC6A19 | SLC6A2 | SLC6A20 | SLC6A3 | SLC6A4 | SLC6A5 | SLC6A6 | SLC6A7 | SLC6A8 | SLC6A9 | SLC7A1 | SLC7A10 | SLC7A11 | SLC7A11-AS1